Drug Type Immune cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism melan-A modulators(Melanoma antigen recognized by T-cells 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma | Preclinical | United States | 26 Sep 2007 |





